Independent Ifenprodil Studies
Our confidence in Ifenprodil as a potentially therapeutic compound for lung disease is based on the data collected from our internal animal studies and is also based on data from other independent studies:
- An independent animal study published by the American Society of Microbiology in mSystems in the December 2019 issue, found that Ifenprodil significantly reduced acute lung injury (ALI) and improved survivability with Avian H5N1 infected mice by 40%. Avian H5N1 is the most lethal form of influenza known to man with an over 50% mortality rate.
- An independent animal study published in-vivo also found that Ifenprodil prolonged survival in mice under anoxic (low oxygen) conditions, as might occur in patients with severely impaired lung function.